Oxalate and Citrate in Humans - Response to Citrate
University of Chicago · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT06944223
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 24
- US sites recruiting
- 1
- Study start
- October 1, 2025
- Record last updated
- December 16, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a single-center study that aims to learn more about how two compounds found in food, oxalate and citrate, interact in the body and may influence a person's chances of forming kidney stones. The study will examine changes in urinary oxalate and citrate levels after participants consume potassium citrate.
Being studied: Kidney stone formers; Control cohort
Conditions: Kidney Stone; Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Stone formers (SF):
- Age 18-70
- History of at least one calcium-based kidney stone
Non-stone formers (NSF):
- Age 18-70
- No history of kidney stone
- 24-hour urine oxalate within laboratory normal range (\<50 mg/day)
Exclusion Criteria
History of primarily uric acid, cysteine, or struvite stones
History of severe acid-base abnormality, very low (less than 100 mg/day) or very high (greater than 1500 mg/day) urine citrate
Any controls or stone former (SF) participants who cannot stop diuretic medication or alkali supplementation for the course of the study period
Chronic kidney disease (glomerular filtration rate \<75 milliliters per minute per 1.73 square meters [mL/min/1.73 m²])
Non-stone formers (NSF) and stone formers (SF) with extreme levels of urine citrate will be excluded from this small initial study to reduce heterogeneity and remove focus from the extremes of citrate levels.
Recruiting US locations
University of Chicago Medical Center
Chicago, IL 60637
Site contact: Megan Prochaska, MD · 773-702-1000 · mprocha2@medicine.bsd.uchicago.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65